Saudi Arabia Biologics Contract Development Market Size & Outlook
Saudi Arabia biologics contract development market, 2018-2030 (US$M)
Related Markets
Saudi Arabia biologics contract development market highlights
- The Saudi Arabia biologics contract development market generated a revenue of USD 20.5 million in 2023 and is expected to reach USD 30.6 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, microbial source was the largest revenue generating source in 2023.
- Mammalian Source is the most lucrative source segment registering the fastest growth during the forecast period.
Biologics contract development market data book summary
| Market revenue in 2023 | USD 20.5 million |
| Market revenue in 2030 | USD 30.6 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Microbial source |
| Fastest growing segment | Mammalian Source |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microbial Source, Mammalian Source, Other Source |
| Key market players worldwide | WuXi Biologics (Cayman) Inc, FUJIFILM Holdings Corp, AGC Biologics, Thermo Fisher Scientific Inc, Curia, Genscript Biotech Corp Class H, Boehringer Ingelheim Pharma, Abzena, JSR Corp, Bionova Scientific |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.3% of the global biologics contract development market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, UAE biologics contract development market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 30.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Contract Development Market Scope
Biologics Contract Development Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia biologics contract development market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract development market will help companies and investors design strategic landscapes.
Microbial source was the largest segment with a revenue share of 84.39% in 2023. Horizon Databook has segmented the Saudi Arabia biologics contract development market based on microbial source, mammalian source, other source covering the revenue growth of each sub-segment from 2018 to 2030.
The growing need for new clinical trials in different medicinal fields has created space to conduct numbers of clinical trials in Saudi Arabia. The clinical trials administration is formed to provide services professionally by evaluation, registration, and monitoring of trials conducted in Saudi Arabia, which helps protect clinical trial subjects as well as improves experience of investigators in the field of clinical research, while strengthening the capacity of regulatory body and legislative & oversight functions.
Since February 2000, 405 trials have been registered in Saudi Arabia. These trials fall into one of the 22 different ICD-10 codes, and with the top four being neoplasms (92); diseases of the circulatory system (57); endocrine, nutritional, & metabolic diseases (46); and diseases of the respiratory system (25).
About half (200) were classified as trials with both safety and efficacy endpoints. Around 52% were phase IV and 28% were phase III. Saudi Arabia has the largest population in the Gulf, which is expected increase at annual average growth of more than 2% over the next 5 years.
Reasons to subscribe to Saudi Arabia biologics contract development market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia biologics contract development market databook
-
Our clientele includes a mix of biologics contract development market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia biologics contract development market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia biologics contract development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia biologics contract development market size, by source, 2018-2030 (US$M)
Saudi Arabia Biologics Contract Development Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
